Rilapladib
CAS No. 412950-08-4
Rilapladib( SB-659032 | SB 659032 )
Catalog No. M14414 CAS No. 412950-08-4
A potent, selective and oral lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with IC50 of 0.23 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 215 | In Stock |
|
| 10MG | 350 | In Stock |
|
| 25MG | 590 | In Stock |
|
| 50MG | 839 | In Stock |
|
| 100MG | 1143 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRilapladib
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective and oral lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with IC50 of 0.23 nM.
-
DescriptionA potent, selective and oral lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with IC50 of 0.23 nM, for the treatment of Alzheimer's disease and atherosclerosis.Alzheimer Disease Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsSB-659032 | SB 659032
-
PathwayMetabolic Enzyme/Protease
-
TargetPhospholipase
-
RecptorPhospholipase
-
Research AreaNeurological Disease
-
IndicationAlzheimer Disease
Chemical Information
-
CAS Number412950-08-4
-
Formula Weight735.814
-
Molecular FormulaC40H38F5N3O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 86.67 mg/mL 117.79 mM; H2O : < 0.1 mg/mL
-
SMILESO=C(N(C1CCN(CCOC)CC1)CC2=CC=C(C3=CC=C(C(F)(F)F)C=C3)C=C2)CN4C(SCC5=CC=CC(F)=C5F)=CC(C6=C4C=CC=C6)=O
-
Chemical Name2-(2-((2,3-difluorobenzyl)thio)-4-oxoquinolin-1(4H)-yl)-N-(1-(2-methoxyethyl)piperidin-4-yl)-N-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tawakol A, et al. J Am Coll Cardiol. 2014 Jan 7-14;63(1):86-8.
2. Shaddinger BC, et al. PLoS One. 2014 Jan 27;9(1):e83094.
3. Wilensky RL, et al. Curr Opin Lipidol. 2009 Oct;20(5):415-20.
molnova catalog
related products
-
U 73343
U 73343 is an inactive analog of U 73122 and can be used as a negative control. It dose-dependently inhibits acid secretion irrespective of the stimulant.
-
AK106-001616
AK106-001616 (AK 106-001616) is a potent and selective inhibitor of cytosolic phospholipase A2 (cPLA2) with IC50 of 3.8 nM (human cPLA2 enzyme).
-
5-HT1A modulator 1
5-HT1A modulator 1 displays very high affinities for the 5-HT1A, α1-adrenergic receptor, and D2 receptor.
Cart
sales@molnova.com